| Consolidated
statements of cash flows for the years
ended September 30 € in millions |
|
 |
| |
2002 |
2003 |
2004 |
| Net (loss) income |
(1,021) |
(435) |
61 |
| Less:
net loss from discontinued operations |
(4) |
- |
- |
|
| Net (loss) income
from contining operations |
(1,017) |
(435) |
61 |
|
| Adjustments to reconcile
net (loss) income to cash provided by operating
activities: |
|
|
|
| Depreciation
and amortization |
1,370 |
1,437 |
1,320 |
| Acquired in-process
research and development |
37 |
6 |
9 |
| Deferred compensation |
23 |
7 |
2 |
| Provision
for (recovery of) doubtful accounts |
(5) |
(16) |
15 |
| Loss (gain) on sale
of marketable securities |
1 |
(56) |
(9) |
| Loss (gain)
on sale of business |
(39) |
10 |
2 |
Loss
(gain) on disposal of property, plant and
equipment |
2 |
3 |
(5) |
Equity in
(earnings) losses of associated
companies |
47 |
(18) |
14 |
| Loss (gain) on associated
company share issuance |
(18) |
2 |
(2) |
| Minority interests |
(7) |
(8) |
(18) |
| Impairment charges |
51 |
98 |
136 |
| Deferred income
taxes |
(282) |
16 |
96 |
| Changes in operating
assets and liabilities: |
|
|
|
| Trade accounts receivable |
(131) |
(227) |
(219) |
| Inventories |
(28) |
(112) |
(40) |
| Other current assets |
39 |
156 |
154 |
| Trade accounts payable |
40 |
(217) |
228 |
| Accrued liabilities |
86 |
164 |
92 |
| Other current liabilities |
(37) |
(17) |
(22) |
| Other assets and
liabilities |
94 |
(62) |
43 |
|
| Net cash provided
by operating activities |
226 |
731 |
1,857 |
|
| Cash flows from investing
activities: |
|
|
|
Purchases
of marketable securities available
for
sale |
(709) |
(2,752) |
(2,678) |
Proceeds from
sales of marketable securities
available
for sale |
62 |
2,013 |
2,520 |
| Proceeds from
sales of businesses |
96 |
164 |
9 |
| Business interests, net
of cash acquired |
156 |
6 |
(29) |
| Investment
in associated and related companies |
(178) |
(76) |
(386) |
| Purchases
of intangible assets |
(55) |
(58) |
(125) |
| Purchases
of property, plant and equipment |
(643) |
(872) |
(1,163) |
Proceeds from
sales of property, plant
and
equipment |
27 |
53 |
43 |
|
| Net cash used in investing
activities |
(1,244) |
(1,522) |
(1,809) |
|
| Cash flows from financing
activities: |
|
|
|
| Net change
in short-term debt |
4 |
(36) |
62 |
Net change
in related party financial receivables
and
payables |
(40) |
(76) |
75 |
| Proceeds from
issuance of long-term debt |
1,482 |
700 |
- |
| Principal
repayments of long-term debt |
(21) |
(25) |
(549) |
| Change in
restricted cash |
15 |
3 |
(43) |
Proceeds from
issuance of shares to minority
interest |
- |
- |
53 |
| Proceeds from
issuance of ordinary shares |
8 |
- |
- |
|
| Net cash provided
by (used in) financing activities |
1,448 |
566 |
(402) |
|
| Effect of foreign
exchange rate changes on cash and cash equivalents |
1 |
(4) |
(7) |
| Net increase (decrease)
in cash and cash equivalents from continuing operations |
431 |
(229) |
(361) |
| Net increase (decrease)
in cash and cash equivalents from discontinued
operation |
11 |
(1) |
- |
| Cash and cash equivalents
at beginning of period |
757 |
1,199 |
969 |
| Cash and cash equivalents
at end of period |
1,199 |
969 |
608 |
|
| See accompanying
notes to the consolidated financial statements. |
|